Uteroplacental Circulation

Introduction

• The uteroplacental circulation is a unique vascular system that facilitates the exchange of oxygen, nutrients, and waste products between the mother and fetus.¹ It represents the sole pathway for fetal oxygenation and metabolic support.
• For anesthesiologists, understanding this physiology is crucial; maternal hemodynamics, anesthesia techniques, and drug choices all influence uteroplacental perfusion, and consequently, fetal well-being.
• Under normal conditions, uteroplacental blood flow increases progressively during Pregnancy, from approximately 50–100 mL/min pre-pregnancy to 700–900 mL/min at term, constituting roughly 10% of maternal cardiac output.
• Unlike other vascular beds, this circulation lacks autoregulation and is entirely dependent on maternal blood pressure and uterine vascular resistance.

Uteroplacental Blood Flow

Anatomy

• When a woman is not pregnant, the uterus receives 50 to 100 mL/min of blood flow.
• By 20 weeks, uterine blood flow reaches approximately 350 mL/min (≈10% of cardiac output) and continues to increase to 700–900 mL/min (15–20%) by term.
• Maternal side: The uterine arteries branch from the internal iliac arteries. These branch into the arcuate arteries, the radial arteries, and the spiral arteries, which open directly into the intervillous space of the placenta.²
• Fetal side: The umbilical arteries (from the fetal internal iliacs) carry deoxygenated blood to the placenta, where exchange occurs across the syncytiotrophoblast membrane, and oxygenated blood returns via the umbilical vein.

Physiology

• The uterine arteries are maximally dilated due to hormonal and structural remodeling.³
• Unlike renal or cerebral circulation, the uteroplacental bed lacks autoregulation—flow varies linearly with maternal perfusion pressure.
• Flow in the intervillous space is non-pulsatile, maintaining continuous exchange.

Factors Affecting Uteroplacental Blood Flow

Maternal Blood Pressure and Cardiac Output

• Decreases in maternal MAP directly reduce perfusion. Aortocaval compression in the supine position increases venous pressure, reducing uterine perfusion; hence, the left lateral tilt is essential.
  • Even a 15° tilt or manual uterine displacement mitigates aortocaval compression and supports venous return.

Uterine Vascular Resistance

• Increased resistance (via vasoconstriction or uterine tone) decreases blood flow. Catecholamine surges, hypocapnia (from hyperventilation), or uterotonic drugs (e.g., oxytocin in high doses, ergometrine) can elevate uterine vascular resistance.
• Uterine vessels retain α-adrenergic receptors; sympathetic stimulation (pain, stress, or vasopressors with α-activity) can markedly reduce flow.

Uterine Tone

• Contractions transiently occlude spiral arteries, decreasing perfusion. Prolonged hypertonus (e.g., after excessive oxytocin) can cause sustained fetal hypoxia.

Maternal Oxygenation and Hemoglobin

• Maternal hypoxemia, anemia, or acid-base imbalance all reduce fetal oxygen delivery, even if total blood flow is unchanged.⁴

Drugs and Sympathetic Activity

• Maternal stress or pain increases catecholamines, which activate α-adrenergic vasoconstriction and cause reduced uterine flow. Adequate analgesia during labor helps preserve perfusion.

Fetal Considerations

Fetal Oxygen Delivery

Fetal oxygenation is determined by:

• Delivery of oxygen to the placenta. This depends on placental blood flow and maternal blood oxygen content, which in turn depends on maternal PaO₂ and maternal hemoglobin.
• Transfer of oxygen across the placenta. Several factors aid the transfer of oxygen from maternal hemoglobin A (HbA) to fetal hemoglobin (HbF).
  • A large oxygen pressure gradient across the placenta.
  • HbF has a higher O₂-binding than maternal HbA (see below)
  • Double Bohr effect (see below)

HbF and Oxyhemoglobin Dissociation Curve

• HbF causes a left shift of the oxyhemoglobin dissociation curve due to higher oxygen affinity and reduced binding to 2,3-DPG. This makes fetal hemoglobin more saturated at lower PO_₂ levels.
• The placenta operates at low PO_₂. Because HbF maintains higher saturation at a given PO_₂, oxygen transfer from mother to fetus remains favorable. Maternal hypotension or hypoxemia significantly reduces fetal oxygen delivery.
• Maternal oxygenation is the strongest determinant of fetal oxygenation. Even brief maternal desaturation during induction can rapidly compromise fetal oxygenation.

Double Bohr Effect

• CO_₂ transfer from fetus to mother makes maternal blood more acidic (right shift in the oxyhemoglobin dissociation curve, resulting in better unloading) and fetal blood more alkaline (left shift resulting in better oxygen loading). This enhances oxygen transfer.
• Avoid both maternal hyperventilation (reduces O_₂ unloading) and hypoventilation (maternal hypoxemia). Maintaining normocapnia is recommended.
• The Haldane effect further facilitates CO_₂ transfer as maternal deoxygenation increases CO_₂ carrying capacity.

Effects of Anesthetic Agents on Uteroplacental Blood Flow

Volatile and Inhalational Anesthetics

• Inhalational agents (e.g., sevoflurane, desflurane, isoflurane) reduce uterine tone and vasodilate the uterine vasculature at 1 minimum alveolar concentration (MAC) or less, usually maintaining or slightly improving flow.⁵
• However, at greater than 1 MAC, systemic hypotension can outweigh the benefits and decrease uterine perfusion.
• Nitrous oxide has minimal hemodynamic effect but no proven uteroplacental benefit or harm.

Intravenous Induction Agents

• Propofol causes dose-dependent hypotension from vasodilation and negative inotropy. This can lead to decreased perfusion if not corrected with fluids or vasopressors.
• Etomidate causes minimal cardiovascular depression and maintains uterine perfusion.
• Ketamine increases MAP and cardiac output but may raise uterine tone in high doses. This may lead to a potential reduction in flow. Small doses (< 1 mg/kg) are generally safe.

Opioids

• Opioids have minimal direct effect on uterine blood flow at clinical doses. Indirect decreases can occur via maternal hypotension or respiratory depression, leading to hypoxemia.

Regional Anesthesia

• Epidural or spinal anesthesia can lower maternal systemic vascular resistance and MAP, decreasing perfusion pressure.
• Prompt treatment with fluids and vasopressors (e.g., phenylephrine or ephedrine) restores flow. Ephedrine was historically preferred for uterine perfusion, but phenylephrine is now favored due to better fetal acid-base outcomes when maternal blood pressure is maintained.⁵
• A phenylephrine infusion (50–100 µg/min) titrated to maintain MAP is current practice of the Society for Obstetric Anesthesia and Perinatology and the American Society of Anesthesiologists.

Vasopressors

• Phenylephrine preserves fetal pH better than ephedrine because it avoids fetal metabolic stimulation and acidosis, provided maternal cardiac output is maintained.
• Goal: Maintain maternal MAP within 90–100% of baseline to ensure stable uteroplacental perfusion.